Cell entry mechanisms of SARS-CoV-2

Cited by (1,003)

Items 401–500 of 1,003

1. Computational repurposing of tamibarotene against triple mutant variant of SARS-CoV-2
   Somdutt Mujwar · 2021 · Computers in Biology and Medicine
2. An airway organoid-based screen identifies a role for the HIF1α-glycolysis axis in SARS-CoV-2 infection
   Xiaohua Duan, Xuming Tang, Manoj S. Nair, Tuo Zhang, Yunping Qiu, Wei Zhang, Pengfei Wang, Yaoxing Huang, Jenny Xiang, Hui Wang et al. · 2021 · Cell Reports
3. Do genetic polymorphisms in angiotensin converting enzyme 2 ( ACE2 ) gene play a role in coronavirus disease 2019 (COVID-19)?
   Giuseppe Lippi, Carl J. Lavie, Brandon Michael Henry, Fabián Sanchis‐Gomar · 2020 · Clinical Chemistry and Laboratory Medicine (CCLM)
4. Nicotine and the nicotinic cholinergic system in COVID‐19
   Yousef Tizabi, Bruk Getachew, Robert Copeland, Michael Aschner · 2020 · FEBS Journal
5. Viral infection and smell loss: The case of COVID‐19
   Isaías Glezer, Alexandre Bruni‐Cardoso, Deborah Schechtman, Bettina Malnic · 2020 · Journal of Neurochemistry
6. Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review)
   Silvia Vivarelli, Luca Falzone, Francesco Torino, Giuseppa Scandurra, Giulia Lo Russo, Roberto Bordonaro, Francesco Pappalardo, Demetrios A. Spandidos, Giuseppina Raciti, Massimo Libra · 2020 · International Journal of Oncology
7. Free Energy Landscapes from SARS-CoV-2 Spike Glycoprotein Simulations Suggest that RBD Opening Can Be Modulated via Interactions in an Allosteric Pocket
   Lucy Fallon, Kellon A. A. Belfon, Lauren E. Raguette, Yuzhang Wang, Darya Stepanenko, Abbigayle E. Cuomo, Jose Guerra, Stephanie Budhan, Sarah Varghese, Christopher P. Corbo et al. · 2021 · Journal of the American Chemical Society
8. Pomegranate peel extract polyphenols attenuate the SARS-CoV-2 S-glycoprotein binding ability to ACE2 Receptor: In silico and in vitro studies
   Relja V. Suručić, Maja Travar, Miroslav R Petković, Biljana Tubić, Miloš P. Stojiljković, Milkica Grabež, Katarina Šavikin, Gordana M. Zdunić, Ranko Škrbić · 2021 · Bioorganic Chemistry
9. Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility
   Nayara Azinheira Nobrega Cruz, Danielle Stoll, Dulce Elena Casarini, Mariane Bertagnolli · 2021 · Clinical Science
10. Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
    Hannah A. D. King, Michael Gordon Joyce, Inès Lakhal-Naouar, Aslaa Ahmed, Camila Macedo Cincotta, Caroline Subra, Kristina K. Peachman, Holly R. Hack, Rita E. Chen, Paul V. Thomas et al. · 2021 · Proceedings of the National Academy of Sciences
11. DNA-Functionalized Ti3C2Tx MXenes for Selective and Rapid Detection of SARS-CoV-2 Nucleocapsid Gene
    Winston Yenyu Chen, Hang Lin, Amit Kumar Barui, Ana María Ulloa Gómez, Michael K. Wendt, Lia Stanciu · 2021 · ACS Applied Nano Materials
12. Inhibitors of thiol-mediated uptake
    Yangyang Cheng, Anh‐Tuan Pham, Takehiro Kato, Bumhee Lim, Dimitri Moreau, Javier López‐Andarias, Lili Zong, Naomi Sakai, Stefan Matile · 2020 · Chemical Science
13. Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2
    Sheng Liu, Jikui Shen, Shuyi Fang, Kailing Li, Juli Liu, Lei Yang, Chang‐Deng Hu, Jun Wan · 2020 · Frontiers in Microbiology
14. Hemagglutinin Subtype Specificity and Mechanisms of Highly Pathogenic Avian Influenza Virus Genesis
    Anja C. M. de Bruin, Mathis Funk, Monique I. J. Spronken, Alexander P. Gultyaev, Ron A. M. Fouchier, Mathilde Richard · 2022 · Viruses
15. SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in Cells
    Ana Dominguez Andres, Yongmei Feng, Alexandre Rosa Campos, Jun Yin, Chih-Cheng Yang, Brian P. James, Rabi Murad, Hyungsoo Kim, Aniruddha J. Deshpande, David Ezra Gordon et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
16. Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein
    Lin Wang, Junhu Zhou, Qixue Wang, Yunfei Wang, Chunsheng Kang · 2020 · Theranostics
17. Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis
    Iago Carvalho Schultz, Ana Paula Santin Bertoni, Márcia Rosângela Wink · 2021 · Stem Cell Reviews and Reports
18. Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies
    M. Finkelstein, Adam G. Mermelstein, Emma Parker Miller, P. Seth, Erik-Stephane D. Stancofski, D. Fera · 2021 · Viruses
19. Electrochemical Biosensors for the Detection of SARS-CoV-2 and Other Viruses
    Saim Imran, Soha Ahmadi, Kağan Kerman · 2021 · Micromachines
20. Comparative Perturbation-Based Modeling of the SARS-CoV-2 Spike Protein Binding with Host Receptor and Neutralizing Antibodies: Structurally Adaptable Allosteric Communication Hotspots Define Spike Sites Targeted by Global Circulating Mutations
    Gennady M. Verkhivker, Steve Agajanian, Deniz Yaşar Öztaş, Grace Gupta · 2021 · Biochemistry
21. The investigation of mRNA vaccines formulated in liposomes administrated in multiple routes against SARS-CoV-2
    Hai Huang, Caili Zhang, Shuping Yang, Wen Xiao, Qian Zheng, Xiangrong Song · 2021 · Journal of Controlled Release
22. The N-terminal domain of spike glycoprotein mediates SARS-CoV-2 infection by associating with L-SIGN and DC-SIGN
    Soh, Wai Tuck, Liu, Yafei, Nakayama, Emi E., Ono, Chikako, Torii, Shiho, Nakagami, Hironori, Matsuura, Yoshiharu, Shioda, Tatsuo, Arase, Hisashi · 2020
23. Quantitative determination of mechanical stability in the novel coronavirus spike protein
    Rodrigo A. Moreira, Mateusz Chwastyk, Joseph L. Baker, Horacio V. Guzman, Adolfo B. Poma · 2020 · Nanoscale
24. ACE2 & TMPRSS2 Expressions in Head & Neck Tissues: A Systematic Review
    Jerome Rene Lechien, Thomas Radulesco, Christian Calvo‐Henríquez, Carlos Miguel Chiesa-Estomba, Stéphane Hans, Maria Rosaria Barillari, Giovanni Cammaroto, Géraldine Descamps, Julien Wen Hsieh, Luigi Angelo Vaira et al. · 2020 · Head and Neck Pathology
25. Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus
    Nan Wang, Shengli Han, Rui Liu, Liesu Meng, Huaizhen He, Yongjing Zhang, Cheng Wang, Yanni Lv, Jue Wang, Xiaowei Li et al. · 2020 · Phytomedicine
26. Molecular Simulations and Network Modeling Reveal an Allosteric Signaling in the SARS-CoV‑2 Spike Proteins
    Gennady M. Verkhivker · 2020 · Journal of Proteome Research
27. Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through Transplantation
    Amaury Gaussen, Laura Hornby, Gary Rockl, Sheila F. O’Brien, Gilles Delage, Ruth Sapir‐Pichhadze, Steven J. Drews, Matthew John Weiss, Antoine Lewin · 2021 · Transplantation
28. Oxidative stress and inflammatory markers in patients with COVID-19: Potential role of RAGE, HMGB1, GFAP and COX-2 in disease severity
    Fabíolla Rocha Santos Passos, Luana Heimfarth, Brenda Souza Monteiro, Cristiane Bani Corrêa, Tatiana Rodrigues de Moura, Adriano Antunes de Souza Araújo, Paulo Ricardo Martins‐Filho, Lucindo José Quintans‐Júnior, Jullyana de Souza Siqueira Quintans · 2022 · International Immunopharmacology
29. Rapid, Point-of-Care scFv-SERS Assay for Femtogram Level Detection of SARS-CoV-2
    Delphine Antoine, Moein Mohammadi, Madison Vitt, Julia Marie Dickie, Sharmin Sultana Jyoti, Maura A. Tilbury, Patrick Alfred Johnson, Karen Wawrousek, J. Gerard Wall · 2022 · ACS Sensors
30. SNPs of ACE1 (rs4343) and ACE2 (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease
    Nahid Alimoradi, Moein Sharqi, Dena Firouzabadi, Mohammad Moein Sadeghi, Seyed Mohammad Iman Moezzi, Negar Firouzabadi · 2022 · Virology Journal
31. SARS-CoV-2 ORF7a potently inhibits the antiviral effect of the host factor SERINC5
    Uddhav Timilsina, Supawadee Umthong, Emily B. Ivey, Brandon Waxman, Spyridon Stavrou · 2022 · Nature Communications
32. Clinical Characteristics and Risk Factors for COVID-19 Infection and Disease Severity: A Nationwide Observational Study in Estonia
    Tatjana Meister, Heti Pisarev, Raivo Kolde, Ruth Kalda, Kadri Suija, Lili A. Milani, Liis Karo-Astover, Marko Piirsoo, Anneli Uusküla · 2021 · PLoS ONE
33. Fluid nanoporous microinterface enables multiscale-enhanced affinity interaction for tumor-derived extracellular vesicle detection
    Qi Niu, Jiafeng Gao, Kaifeng Zhao, Xiaofeng Chen, Xiaolin Lin, Chen Huang, Yu An, Xiuying Xiao, Qiaoyi Wu, Liang Cui et al. · 2022 · Proceedings of the National Academy of Sciences
34. Pinpointing the potential hits for hindering interaction of SARS-CoV-2 S-protein with ACE2 from the pool of antiviral phytochemicals utilizing molecular docking and molecular dynamics (MD) simulations
    Chirag Patel, Dweipayan Goswami, Dharmesh G. Jaiswal, Robin M. Parmar, Hitesh Solanki, Himanshu A. Pandya · 2021 · Journal of Molecular Graphics and Modelling
35. Sterically confined rearrangements of SARS-CoV-2 Spike protein control cell invasion
    Esteban Dodero‐Rojas, José N. Onuchic, Paul C. Whitford · 2021 · eLife
36. The D614G Virus Mutation Enhances Anosmia in COVID-19 Patients: Evidence from a Systematic Review and Meta-analysis of Studies from South Asia
    Christopher S. von Bartheld, Molly M. Hagen, Rafał Butowt · 2021 · ACS Chemical Neuroscience
37. Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach
    Taj Mohammad, Arunabh Choudhury, Insan Habib, Purva Asrani, Yash Mathur, Mohd Umair, Farah Anjum, Alaa Shafie, Dharmendra Kumar Yadav, Md. Imtaiyaz Hassan · 2021 · Frontiers in Cellular and Infection Microbiology
38. Endoplasmic Reticulum Chaperones in Viral Infection: Therapeutic Perspectives
    Évelyne Kohli, Sébastien Causse, Valentin Baverel, Laurence Dubrez, Natalia Borges-Bonan, Oleg N. Demidov, Carmen Garrido · 2021 · Microbiology and Molecular Biology Reviews
39. Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2
    Fakry Fahmy Mohamed, Darisuren Anhlan, Michael Schöfbänker, André Schreiber, Nica Classen, Andreas Hensel, Georg Hempel, Wolfgang Scholz, Joachim Kühn, Eike Roman Hrincius et al. · 2022 · Pharmaceuticals
40. Choosing a cellular model to study SARS-CoV-2
    Gabriel Augusto Pires de Souza, Marion Le Bideau, Céline Boschi, Nathalie Wurtz, Philippe Colson, Sarah Aherfi, Christian Albert Devaux, Bernard La Scola · 2022 · Frontiers in Cellular and Infection Microbiology
41. Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials
    Rami A. Al‐Horani, Srabani Kar, Kholoud F. Aliter · 2020 · International Journal of Molecular Sciences
42. Classical and alternative receptors for SARS‐CoV‐2 therapeutic strategy
    Siti Fathiah Masre, Nurul Farhana Jufri, Farah Wahida Ibrahim, Sayyidi Hamzi Abdul Raub · 2020 · Reviews in Medical Virology
43. Microarray patches enable the development of skin-targeted vaccines against COVID-19
    Emrullah Korkmaz, Stephen C. Balmert, Tina L. Sumpter, Cara Donahue Carey, Géza Erdös, Louis D. Falo · 2021 · Advanced Drug Delivery Reviews
44. Development and application of therapeutic antibodies against COVID-19
    Lin-jin Ning, H. B. Abagna, Qianhu Jiang, Siqi Liu, Jian Huang · 2021 · International Journal on Biological Sciences
45. Could live attenuated vaccines better control COVID-19?
    Shinya Okamura, Hirotaka Ebina · 2021 · Vaccine
46. A Review of Human Coronaviruses’ Receptors: The Host-Cell Targets for the Crown Bearing Viruses
    Aaya M. Nassar, Ibrahim M. Ibrahim, Fatma G. Amin, Merna Magdy, Ahmed M. Elgharib, Eman B. Azzam, Filopateer Nasser, Kirllos Yousry, Israa Mohamed Shamkh, Samah M. Mahdy et al. · 2021 · Molecules
47. COVID-19 and pregnancy: clinical outcomes; mechanisms, and vaccine efficacy
    Deepak Kumar, Sonam Verma, Indira U. Mysorekar · 2022 · Translational research
48. Systematic review on role of structure based drug design (SBDD) in the identification of anti-viral leads against SARS-Cov-2
    Nilesh Gajanan Bajad, Rayala Swetha, Gopichand Gutti, Anjali Sharma, Meenakshi Singh, Ashok Kumar, Sushil Kumar Singh · 2021 · Current Research in Pharmacology and Drug Discovery
49. Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators
    Daniela Ricci, Marilena Paola Etna, Fabiana Rizzo, Silvia Sandini, Martina Severa, Eliana Marina Coccia · 2021 · International Journal of Molecular Sciences
50. Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection
    Jinkai Zang, Yuanfei Zhu, Yu Zhou, Chenjian Gu, Yufang Yi, Shuxia Wang, Shiqi Xu, Gaowei Hu, Shujuan Du, Yannan Yin et al. · 2021 · Cell Discovery
51. Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy
    Shouheng Jin, Xing He, Ling Ma, Zhen Zhuang, Yiliang Wang, Meng Lin, Sihui Cai, Lu Wei, Zheyu Wang, Zhiyao Zhao et al. · 2022 · Nature Communications
52. A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro
    Mary Hongying Cheng, Rebecca A. Porritt, Magali Noval Rivas, James Krieger, Asli Beyza Ozdemir, Gustavo Garcia, Vaithilingaraja Arumugaswami, Bettina C. Fries, Moshe Arditi, İvet Bahar · 2021 · Structure
53. Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells
    Syairah Hanan Shaharuddin, Victoria Wang, Roberta de Souza Santos, Andrew R. Gross, Yizhou Wang, Harneet Jawanda, Yi Zhang, Wohaib Hasan, Gustavo Garcia, Vaithilingaraja Arumugaswami et al. · 2021 · Frontiers in Cellular and Infection Microbiology
54. SARS-CoV-2 Infection and Lung Regeneration
    Fuxiaonan Zhao, Qingwen Ma, Qing Yue, Huaiyong Chen · 2022 · Clinical Microbiology Reviews
55. Trypsin, chymotrypsin and elastase in health and disease
    Oladoyin Grace Famutimi, Victor Gbolahan Adebiyi, Bukola Grace Akinmolu, Omoniyi Vincent Dada, Isaac Olusanjo Adewale · 2024 · Future Journal of Pharmaceutical Sciences
56. The Novel Insight of SARS-CoV-2 Molecular Biology and Pathogenesis and Therapeutic Options
    Arghavan Asghari, Mohsen Naseri, Hamidreza Safari, Ehsan Saboory, Negin Parsamanesh · 2020 · DNA and Cell Biology
57. Dynamic Network Modeling of Allosteric Interactions and Communication Pathways in the SARS-CoV-2 Spike Trimer Mutants: Differential Modulation of Conformational Landscapes and Signal Transmission via Cascades of Regulatory Switches
    Gennady M. Verkhivker, Luisa Di Paola · 2021 · The Journal of Physical Chemistry B
58. Machine Learning Reveals the Critical Interactions for SARS-CoV-2 Spike Protein Binding to ACE2
    Ànna Pavlova, Zijian Zhang, Atanu Acharya, Diane L. Lynch, Yui Tik Pang, Zhongyu Mou, Jerry M. Parks, Christophe J. Chipot, James C. Gumbart · 2021 · The Journal of Physical Chemistry Letters
59. Machine Learning Models Identify Inhibitors of SARS-CoV-2
    Victor Oliveira Gawriljuk, Phyo Phyo Kyaw Zin, Daniel H. Foil, Jean Bernatchez, Sungjun Beck, Nathan Beutler, James Ricketts, Linlin Yang, Thomas Rogers, Ana C. Puhl et al. · 2021 · Journal of Chemical Information and Modeling
60. Hamster organotypic modeling of SARS-CoV-2 lung and brainstem infection
    Marion Ferren, Valérie Favède, Didier Décimo, Mathieu Iampietro, Nicole A. P. Lieberman, Jean‐Luc Weickert, Rodolphe Pélissier, Magalie Mazelier, Olivier Terrier, Anne Moscona et al. · 2021 · Nature Communications
61. Alterations in heparan sulfate proteoglycan synthesis and sulfation and the impact on vascular endothelial function
    Daniëlle Pretorius, Robert P. Richter, Tanya Anand, Jessica C. Cardenas, Jillian R. Richter · 2022 · Matrix Biology Plus
62. Implications of inadequate water and sanitation infrastructure for community spread of COVID-19 in remote Alaskan communities
    Laura Eichelberger, Subhabrata Dev, Tricia S. Howe, David L. Barnes, Eric Bortz, Brandon R. Briggs, Patricia A. L. Cochran, Aaron D. Dotson, Devin M. Drown, Micah B. Hahn et al. · 2021 · The Science of The Total Environment
63. Identification of an anti–SARS–CoV-2 receptor-binding domain–directed human monoclonal antibody from a naïve semisynthetic library
    Hilal Ahmad Parray, Adarsh Kumar Chiranjivi, Shailendra Asthana, Naveen Yadav, Tripti Shrivastava, Shailendra Mani, Chandresh Sharma, Preeti Vishwakarma, Supratik Das, Kamal S. Pindari et al. · 2020 · Journal of Biological Chemistry
64. The influence of ABO blood groups on COVID-19 susceptibility and severity: A molecular hypothesis based on carbohydrate-carbohydrate interactions
    José Caetano Silva-Filho, Cynthia Germoglio Farias de Melo, Janaína Lima de Oliveira · 2020 · Medical Hypotheses
65. Genetic variability in the expression of the SARS-CoV-2 host cell entry factors across populations
    Lourdes Ortiz‐Fernández, Amr H. Sawalha · 2020 · Genes and Immunity
66. Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review
    Ettore Crimi, Giuditta Benincasa, Neisaliz Figueroa-Marrero, Massimiliano Galdiero, Claudio Napoli A · 2020 · British Journal of Anaesthesia
67. Pathogenesis‐directed therapy of 2019 novel coronavirus disease
    Charles W. Stratton, Yi‐Wei Tang, Hongzhou Lu · 2020 · Journal of Medical Virology
68. COVID-19 during Pregnancy and Postpartum:
    Sreus A. G. Naidu, Roger Clemens, Peter Pressman, Mehreen Zaigham, Kamran Kadkhoda, Kelvin J.A. Davies, A. Satyanarayan Naidu · 2020 · Journal of Dietary Supplements
69. Characterization of Structural and Energetic Differences between Conformations of the SARS-CoV-2 Spike Protein
    Rodrigo A. Moreira, Horacio V. Guzman, Subramanian Boopathi, Joseph L. Baker, Adolfo B. Poma · 2020 · Materials
70. Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury
    Murat Öz, Dietrich Ernst Lorke · 2021 · Biomedicine & Pharmacotherapy
71. SARS-CoV-2 variants reveal features critical for replication in primary human cells
    Marie O. Pohl, Idoia Busnadiego, Verena Kufner, Irina Glas, Umut Karakus, Stefan Schmutz, Maryam Zaheri, Irène A. Abela, Alexandra Trkola, Michael Huber et al. · 2021 · PLoS Biology
72. Computational design and modeling of nanobodies toward SARS‐CoV‐2 receptor binding domain
    Jingyi Yang, Zhao Zhang, Fengyuan Yang, Haiwei Zhang, Haibo Wu, Feng Zhu, Weiwei Xue · 2021 · Chemical Biology & Drug Design
73. Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients
    Yasuo Okada, Ken Yoshimura, Shuji Toya, Makoto Tsuchimochi · 2021 · Japanese Dental Science Review
74. A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19
    Emmanuelle Logette, Charlotte Lorin, Cyrille Favreau, Eugenia Oshurko, Jay S. Coggan, Francesco Casalegno, Mohameth François Sy, Caitlin Monney, Marine Bertschy, Émilie Delattre et al. · 2021 · Frontiers in Public Health
75. SARS-CoV-2 evolved variants optimize binding to cellular glycocalyx
    Sang Hoon Kim, Fiona L. Kearns, Mia A. Rosenfeld, Lane William Votapka, Lorenzo Casalino, Micah Papanikolas, Rommie E. Amaro, Ronit Freeman · 2023 · Cell Reports Physical Science
76. Animal coronaviruses and SARS‐CoV‐2
    Guangzhi Zhang, Bin Li, Dongwan Yoo, Tong Qin, Xiaodong Zhang, Yaxiong Jia, Shangjin Cui · 2020 · Transboundary and Emerging Diseases
77. Diseases with health disparities as drivers of COVID‐19 outcome
    John T. Moore, William F. Pilkington, Deepak Kumar · 2020 · Journal of Cellular and Molecular Medicine
78. Nanotraps for the containment and clearance of SARS-CoV-2
    Min Chen, Jillian Rosenberg, Xiaolei Cai, A. Lee, Jiu-Yun Shi, Mindy Nguyen, T. Wignakumar, Vikranth R. Mirle, Arianna Edobor, John F. Fung et al. · 2021 · bioRxiv
79. Expression and characterization of SARS-CoV-2 spike proteins
    Jeffrey M. Schaub, Chia-Wei Chou, Hung-Che Kuo, Kamyab Javanmardi, Ching-Lin Hsieh, J. Goldsmith, Andrea M. DiVenere, Kevin C. Le, D. Wrapp, P. O. Byrne et al. · 2021 · Nature Protocols
80. Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection
    Pasquale Campana, Valentina Parisi, Dario Leosco, Debora Bencivenga, Fulvio Della Ragione, Adriana Borriello · 2020 · Cells
81. Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
    Michele Carbone, John A. Lednicky, Shu‐Yuan Xiao, Mario Venditti, Enrico M Bucci · 2021 · Journal of Thoracic Oncology
82. Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin–Kallikrein System in Severe COVID-19
    Eli Mansour, André C. Palma, Raisa Gusso Ulaf, Luciana C. Ribeiro, Ana Flávia Bernardes, Thyago A. Nunes, Marcus Vinicius Rodrigues de Agrela, Bruna Bombassaro, Milena Monfort‐Pires, Rafael Ludemann Camargo et al. · 2021 · Viruses
83. Integrated Biophysical Modeling of the SARS-CoV-2 Spike Protein Binding and Allosteric Interactions with Antibodies
    Gennady M. Verkhivker, Luisa Di Paola · 2021 · The Journal of Physical Chemistry B
84. Insights into SARS-CoV-2 Persistence and Its Relevance
    Belete Ayele Desimmie, Yonas Raru, Hesham Awadh, Peimei He, Samson Teka, Kara S. Willenburg · 2021 · Viruses
85. Fluorine in Medicinal Chemistry: In Perspective to COVID-19
    Cheng Zhang · 2022 · ACS Omega
86. Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target
    Lixiao Xing, Zhimin Liu, Xinling Wang, Qianying Liu, Wei Xu, Qiyu Mao, Xiang Zhang, Aihua Hao, Shuai Xia, Zezhong Liu et al. · 2025 · Cell
87. Unusual Features of the SARS-CoV-2 Genome Suggesting Sophisticated Laboratory Modification Rather Than Natural Evolution and Delineation of Its Probable Synthetic Route
    Yan, Li-Meng, Shu Kang, Shanchang Hu · 2020 · Zenodo (CERN European Organization for Nuclear Research)
88. Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease
    M. Nazmul Hoque, Abed Chaudhury, Md. Abdul Mannan Akanda, M. Anwar Hossain, Tofazzal Islam · 2020 · PeerJ
89. COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response
    Swati Jain, Himanshu Batra, Poonam Yadav, Subhash Chand · 2020 · Vaccines
90. SARS-CoV-2 receptor is co-expressed with elements of the kinin–kallikrein, renin–angiotensin and coagulation systems in alveolar cells
    Davi Sidarta-Oliveira, Carlos Poblete Jara, Adriano José Ferruzzi, Munir S. Skaf, William H. Velander, ELIANA PEREIRA DE ARAUJO, Licio Augusto Velloso · 2020 · Scientific Reports
91. Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): In silico analysis
    Bilal Çakır, Betül Okuyan, Göksel Şener, Tuğba Tunalı Akbay · 2020 · European Journal of Pharmacology
92. Molecular Aspects Concerning the Use of the SARS-CoV‑2 Receptor Binding Domain as a Target for Preventive Vaccines
    Yury Valdés-Balbín, Darielys Santana-Mederos, Françoise Paquet, Sonsire Fernández-Castillo, Yanet Climent, Fabrizio Chiodo, Laura Rodríguez, Belinda Sánchez Ramírez, Kalet León, Tays Hernández et al. · 2021 · ACS Central Science
93. SARS-CoV-2 infection induces the activation of tissue factor–mediated coagulation via activation of acid sphingomyelinase
    Jue Wang, Usha R. Pendurthi, Guohua Yi, L. Vijaya Mohan Rao · 2021 · Blood
94. Molecular biology of the SARs‐CoV‐2 spike protein: A review of current knowledge
    Chaogeng Zhu, Guiyun He, Qinqin Yin, Lin Zeng, Xiangli Ye, Yongzhong Shi, Wei Xu · 2021 · Journal of Medical Virology
95. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents
    Jie Mei, Yatong Zhou, Xinping Yang, Fan Zhang, Xiufeng Liu, Boyang Yu · 2021 · Journal of Ethnopharmacology
96. Common Inflammatory Mechanisms in COVID-19 and Parkinson’s Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention
    Valery Danilenko, Andrey Devyatkin, Mariya Marsova, Madina Shibilova, Rustem Abuzarovich Ilyasov, Vladimir Shmyrev · 2021 · Journal of Inflammation Research
97. A common TMPRSS2 variant has a protective effect against severe COVID-19
    Alessia David, Nick Parkinson, Thomas P. Peacock, Erola Pairo‐Castineira, Tarun Khanna, Aurélie Cobat, Albert Tenesa, Vanessa Sancho‐Shimizu, GenOMICC Investigators, ISARIC4C Investigators et al. · 2022 · Current Research in Translational Medicine
98. Influenza A virus exploits transferrin receptor recycling to enter host cells
    Béryl Mazel‐Sanchez, Chengyue Niu, Nathalia Williams, Michaël Bachmann, Hélèna Choltus, Filo Silva, Véronique Serre‐Beinier, Wolfram Karenovicŝ, Justyna Iwaszkiewicz, Vincent Zoete et al. · 2023 · Proceedings of the National Academy of Sciences
99. Underscoring the immense potential of chitosan in fighting a wide spectrum of viruses: A plausible molecule against SARS-CoV-2?
    Nivya Sharma, Chandrima Modak, Pankaj Kumar Singh, Rahul Kumar, Dharmendra Kumar Khatri, Shashi Bala Singh · 2021 · International Journal of Biological Macromolecules
100. Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment
     Sameer Kumar Malladi, Randhir Singh, Suman Pandey, Savitha Gayathri, Kawkab Kanjo, Shahbaz Ahmed, M. S. A. Alam Khan, Parismita Kalita, Nidhi Girish, Aditya Upadhyaya et al. · 2020 · Journal of Biological Chemistry